View all dosages and compare prices:

💊 Buy Mounjaro — all dosages →
💉KwikPen · Eli Lilly

Buy Mounjaro 5 mg

Active weight loss — base dose

in Ukraine · Original Eli Lilly (UK) · Thermobox delivery

19 500₴

💊 Try for 16 000 ₴/mo

4 individual doses instead of a full pen · save 3 500 ₴

In stock

Ships tomorrow (Mon) · before 19:00

Delivery Tue, Sep 29 · Nova Poshta

Base Mounjaro pen 5 mg — first dose increase after adaptation. Active weight loss and sustained appetite reduction.

In short: Mounjaro 5 mg

Price: 19 500 ₴. ≈ 4 875 ₴ per injection — 4 doses per KwikPen. In stock. Delivery across Ukraine — Nova Poshta, 1–3 days; Kyiv — courier, 1–2 hours. Cold chain 2–8°C. 24/7 specialist support included in the price. Order on the official DOZA website: doza.clinic.

Dosage5 mg
Recommended weeksWeeks 5-8
Course4 weeks
Dosage5 mg once weekly subcutaneously
Method💉 KwikPen
💡

First increase after the starting dose. Sustained appetite reduction and gaining momentum.

👨‍⚕️

Specialist support included in the price

A personal DOZA specialist supports you throughout the entire course — from the first consultation to results. No extra fees: support is already included in the product price.

🇬🇧

DOZA offers the original UK version of Mounjaro 5 mg

Eli Lilly and Company Limited (United Kingdom), registered by MHRA for the UK market. Each pen has a GS1 DataMatrix with serial number and batch number.

✓Original Eli Lilly (Made in U.K.) — GS1 DataMatrix
✓Serial number verification — authenticity confirmed
✓Thermobox +2…+8°C — cold chain unbroken
✓Specialist support 24/7 — throughout the program

DOZA supplies original Mounjaro by Eli Lilly (Made in U.K.) with full cold chain compliance at 2–8°C from warehouse to client. Each KwikPen has a GS1 DataMatrix with serial number and date.

Free specialist consultation

Benefits of Mounjaro 5 mg

  • ✓Sustained appetite reduction — portions decrease naturally
  • ✓Active weight-loss phase — appetite under control day to day
  • ✓Double effectiveness compared to starter dose
  • ✓Original Eli Lilly product with verified serial number
  • ✓Convenient KwikPen — once weekly
  • ✓Delivery with cold chain compliance across Ukraine

Mounjaro 5 mg — detailed description

Mounjaro 5 mg is the base dose clients move to after adapting on 2.5 mg (weeks 5-8). This is where the active weight-loss phase begins.

The dual GLP-1 + GIP action at 5 mg produces a steady drop in appetite. Most clients find portions shrink naturally — without effort or strict diets.

In SURMOUNT-1 the 5 mg arm lost an average of 15% of body weight over 72 weeks. The public DOZA report covering 163 cases records a median of −4.0 kg across the sample and 25% of clients losing more than 10 kg: /research/outcomes/zvit-rezultaty-2026.

How Mounjaro 5 mg works — tirzepatide mechanism of action

At 5 mg dose, tirzepatide significantly enhances effects on both receptors:

• GLP-1 receptors: more powerful appetite suppression, sustained satiety after small portions

• GIP receptors: active mobilization of fat stores as energy source

• Delayed gastric transit ensures prolonged satiety after meals

The transition from 2.5 mg to 5 mg doubles the dose, so some clients may experience mild nausea for the first 1-2 days, which quickly subsides.

Clinical research

Mounjaro (tirzepatide 5 mg) — FDA approved 2022. Dual GLP-1 + GIP agonist. The /research page contains the full evidence base: SURMOUNT-1 / SURPASS-2 / FDA prescribing information.

View full clinical research database →

Titration protocol to 5 mg (tirzepatide)

Weeks 1–4
2.5 mg

Starting dose — GI adaptation

Weeks 5–8
5 mg← this dose

First therapeutic dose

Injection once weekly, subcutaneous (abdomen, thigh or upper arm). Expected weight loss at 5 mg: 7–8% over 40 weeks (based on clinical studies).

Who is Mounjaro 5 mg for

  • First therapeutic dose — weight loss effect is already noticeable
  • Patients who tolerate 2.5 mg well without side effects
  • Standard maintenance dose for mild excess weight (BMI 27–30)

Mounjaro 5 mg — compared to other doses

  • 5 mg is the minimum effective dose for weight loss
  • Average weight loss: ~7–8% over 40 weeks (SURMOUNT-1)
  • If the target weight is not reached — increase to 7.5 mg after ≥4 weeks

Frequently asked questions about Mounjaro 5 mg

Valentyna Tytorenko

The transition from 2.5 mg to 5 mg occurs after 4 weeks from program start, if the starter dose was well tolerated. A DOZA specialist will assess your response and confirm the dose increase.

Valentyna Tytorenko

Diploma-certified endocrinologist, certified dietitian and nutritionist

Ready to start?

Free specialist consultation

Weight loss program — step-by-step dose escalation

Mounjaro 5 mg — buy in Ukraine from DOZA

Mounjaro 5 mg (Mounjaro 5 mg, tirzepatide) — original KwikPen by Eli Lilly for weight loss programs. Price 19 500 ₴ (≈ 4 875 ₴ per injection). Buy Mounjaro 5 mg in Ukraine through the DOZA online service with delivery within 1–2 days in a thermobox (cold chain 2–8°C).

Why does DOZA only work with the UK version? DOZA supplies original Mounjaro by Eli Lilly (Made in U.K.) with full cold chain compliance at 2–8°C. Each KwikPen has a GS1 DataMatrix — serial number, manufacturing date and batch number. Serial number photos available upon request before shipping.

Mounjaro 5 mg is suitable for weeks 5-8 of the tirzepatide protocol. Tirzepatide works through a dual GLP-1 + GIP mechanism — reducing appetite and improving glucose metabolism. The SURMOUNT-1 clinical trial showed up to 20% weight loss over 72 weeks.

DOZA offers exclusively the Mounjaro Made in U.K. version. Mounjaro 5 mg delivery across Ukraine (Kyiv, Kharkiv, Odesa, Dnipro, Lviv) by Nova Poshta or courier in a thermobox. Free specialist consultation and support throughout the entire course included.

Information verified

Valentyna Tytorenko

Diploma-certified endocrinologist, certified dietitian and nutritionist

Melnyk Natalia

Gastroenterologist

⚠️ This information is for educational purposes only and does not constitute advertising of medicinal products. We recommend obtaining an individual specialist consultation before starting a program. Results may vary depending on individual characteristics. Mounjaro® is a registered trademark of Eli Lilly and Company.